To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes.

United States115th CongressHR-5926House of Representatives
Updated: May 23, 2018

Summary

Naloxone Guidelines Act of 2018 This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone). The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including: co-prescription with an opioid; safe dosages; prescription for non-patients; and standing orders (i.e., orders that allow dispensing without a prescription).

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

  1. Introduced in House

  2. Referred to the House Committee on Energy and Commerce.

    House of Representatives

All available records shown.